BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32975556)

  • 1. Human Papillomavirus Vaccination Prior to Loop Electroexcision Procedure Does Not Prevent Recurrent Cervical High-grade Squamous Intraepithelial Lesions in Women Living With Human Immunodeficiency Virus: A Randomized, Double-blind, Placebo-controlled Trial.
    Firnhaber C; Swarts A; Jezile V; Mulongo M; Goeieman B; Williams S; Faesen M; Michelow P; Wilkin T
    Clin Infect Dis; 2021 Oct; 73(7):e2211-e2216. PubMed ID: 32975556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.
    van de Laar RLO; Hofhuis W; Duijnhoven RG; Polinder S; Melchers WJG; van Kemenade FJ; Bekkers RLM; Van Beekhuizen HJ
    BMC Cancer; 2020 Jun; 20(1):539. PubMed ID: 32517663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Clinical Trial of Human Papillomavirus Test-and-Treat as Compared to Cytology-Based Screening for Prevention of Cervical Cancer Among Women With Human Immunodeficiency Virus: AIDS Clinical Trials Group Protocol A5282.
    Wilkin T; Chen H; Sahasrabuddhe V; Matining R; Mngqibisa R; Chinula L; Mbilizi Y; Magure T; Omoz-Oarhe AE; Rassool M; Riviere C; Bhosale R; Godbole S; Naranjo R; Coombs R; Michelow P; Godfrey C; Firnhaber C
    Clin Infect Dis; 2022 Oct; 75(8):1280-1288. PubMed ID: 35294524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the intraoperative human papillomavirus test as a marker of early cure at 12 months after electrosurgical excision procedure in women with cervical high-grade squamous intraepithelial lesion: a prospective cohort study.
    Rabasa J; Bradbury M; Sanchez-Iglesias JL; Guerrero D; Forcada C; Alcalde A; Pérez-Benavente A; Cabrera S; Ramon-Cajal S; Hernandez J; Dinares C; García A; Centeno C; Gil-Moreno A
    BJOG; 2020 Jan; 127(1):99-105. PubMed ID: 31502397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Papillomavirus Persistence and Association With Recurrent Cervical Intraepithelial Neoplasia After Cryotherapy vs Loop Electrosurgical Excision Procedure Among HIV-Positive Women: A Secondary Analysis of a Randomized Clinical Trial.
    Chung MH; De Vuyst H; Greene SA; Mugo NR; Querec TD; Nyongesa-Malava E; Cagle A; Sakr SR; Luchters S; Temmerman M; Unger ER; McGrath CJ
    JAMA Oncol; 2021 Oct; 7(10):1514-1520. PubMed ID: 34351377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical Intraepithelial Neoplasia 3 (Cervical Intraepithelial Neoplasia 3/High-Grade Squamous Intraepithelial Lesion) in Human Papillomavirus-Vaccinated Women-Results From a Tertiary Referral Center.
    Domröse CM; Wieland U; Pilch H; Einzmann T; Schömig-Markiefka B; Mallmann P; Silling S; Mallmann MR
    J Low Genit Tract Dis; 2022 Apr; 26(2):122-126. PubMed ID: 35019900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)?
    Kang WD; Choi HS; Kim SM
    Gynecol Oncol; 2013 Aug; 130(2):264-8. PubMed ID: 23623831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can We Reduce Overtreatment of Cervical High-Grade Squamous Intraepithelial Lesions?
    Bradbury M; Rabasa J; Murcia MT; Dinarès MC; Sainz A; Castellet C; Pérez-Benavente A; Gil-Moreno A; Centeno C
    J Low Genit Tract Dis; 2022 Jan; 26(1):20-26. PubMed ID: 34928250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G; Yang B; Abdul-Karim FW
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of human papillomavirus prophylactic vaccination after conization in preventing cervical intraepithelial neoplasia recurrence: A prospective observational study in China.
    Chen M; Li C; Cui Q; Zhou C; Chen P; Yao S
    Eur J Obstet Gynecol Reprod Biol; 2023 Jul; 286():10-15. PubMed ID: 37159990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment.
    Hildesheim A; Gonzalez P; Kreimer AR; Wacholder S; Schussler J; Rodriguez AC; Porras C; Schiffman M; Sidawy M; Schiller JT; Lowy DR; Herrero R;
    Am J Obstet Gynecol; 2016 Aug; 215(2):212.e1-212.e15. PubMed ID: 26892991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA): A Trial Protocol.
    Stankiewicz Karita HC; Hauge K; Magaret A; Mao C; Schouten J; Grieco V; Xi LF; Galloway DA; Madeleine MM; Wald A
    JAMA Netw Open; 2019 Apr; 2(4):e190819. PubMed ID: 30977845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of recurrence and its influencing factors in patients with cervical HSIL within 24 months after LEEP].
    Chen LM; Liu L; Tao X; He Y; Guo LP; Zhang HW; Zhou XR; Sui L
    Zhonghua Fu Chan Ke Za Zhi; 2019 Aug; 54(8):534-540. PubMed ID: 31461810
    [No Abstract]   [Full Text] [Related]  

  • 14. Cryotherapy Reduces Progression of Cervical Intraepithelial Neoplasia Grade 1 in South African HIV-Infected Women: A Randomized, Controlled Trial.
    Firnhaber C; Swarts A; Goeieman B; Rakhombe N; Mulongo M; Williamson AL; Michelow P; Ramotshela S; Faesen M; Levin S; Wilkin T
    J Acquir Immune Defic Syndr; 2017 Dec; 76(5):532-538. PubMed ID: 28902073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical outcome and high risk factor for residual lesion analysis of HSIL half a year after loop electrosurgical excision procedure: a clinical study of 1 502 cases].
    Liu L; Chen LM; Tao X; Dai F; Guo LP; Zhang HW; Zhou XR; Sui L
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):751-756. PubMed ID: 29179270
    [No Abstract]   [Full Text] [Related]  

  • 17. Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths.
    Van Kriekinge G; Castellsagué X; Cibula D; Demarteau N
    Vaccine; 2014 Feb; 32(6):733-9. PubMed ID: 24291200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus.
    Palefsky JM; Lensing SY; Belzer M; Lee J; Gaur AH; Mayer K; Futterman D; Stier EA; Paul ME; Chiao EY; Reirden D; Goldstone SE; Tirado M; Cachay ER; Barroso LF; Da Costa M; Darragh TM; Rudy BJ; Wilson CM; Kahn JA
    Clin Infect Dis; 2021 Oct; 73(8):1388-1396. PubMed ID: 33991185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent High-Grade Squamous Intraepithelial Lesion After Loop Excision Procedure Versus Loop Procedure With Top Hat.
    Francoeur AA; Furey KB; Ramirez J; Klomhaus AM; Holschneider C; Garcia LM
    J Low Genit Tract Dis; 2023 Jul; 27(3):193-197. PubMed ID: 37285236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colposcopic performance in a birth cohort previously eligible for human papillomavirus vaccination.
    Sahlgren HAI; Elfgren K; Sparen P; Elfstrom MK
    Am J Obstet Gynecol; 2022 May; 226(5):704.e1-704.e9. PubMed ID: 34954217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.